Cargando…

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

Detalles Bibliográficos
Autores principales:	Chaudhary, Rahul, Bliden, Kevin P., Kreutz, Rolf P., Jeong, Young-Hoon, Tantry, Udaya S., Levy, Jerrold H., Gurbel, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678450/ https://www.ncbi.nlm.nih.gov/pubmed/33251501 http://dx.doi.org/10.1016/j.eclinm.2020.100647

Ejemplares similares

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

Further evidence for the use of aspirin in COVID-19
por: Tantry, Udaya S., et al.
Publicado: (2022)

Influence of Race and Sex on Thrombogenicity in a Large Cohort of Coronary Artery Disease Patients
por: Lev, Eli I., et al.
Publicado: (2014)

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
por: Usman, Abira, et al.
Publicado: (2022)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population
por: Gurbel, Paul A., et al.
Publicado: (2021)

Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
por: Tantry, Udaya S, et al.
Publicado: (2021)

IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients
por: Gurbel, Paul A., et al.
Publicado: (2022)

Personalized antiplatelet therapy: state of the art
por: Gurbel, Paul A, et al.
Publicado: (2012)

Temporal Variability of Platelet Reactivity Phenotype: Another Barrier to Personalized Antiplatelet Strategy Guided by Platelet Function Testing
por: Jeong, Young-Hoon, et al.
Publicado: (2019)

Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study
por: Gurbel, Paul A., et al.
Publicado: (2018)

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19
por: Tantry, Udaya S, et al.
Publicado: (2021)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy?
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
por: Gurbel, Paul A., et al.
Publicado: (2021)

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography
por: Artang, Ramin, et al.
Publicado: (2021)

State of the art: Oral antiplatelet therapy
por: Gurbel, Paul A, et al.
Publicado: (2016)

Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
por: Navarese, Eliano Pio, et al.
Publicado: (2012)

New race and ethnicity standards: elucidating health disparities in diabetes
por: Katzmarzyk, Peter T, et al.
Publicado: (2012)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Can an Old Ally Defeat a New Enemy?
por: Gurbel, Paul A., et al.
Publicado: (2020)

Beyond Race and Place: Distal Sociological Determinants of HIV Disparities
por: Buot, Max-Louis G., et al.
Publicado: (2014)

Diversity in optical coherence tomography normative databases: moving beyond race
por: Mehta, Nihaal, et al.
Publicado: (2020)

How disparities in gamete maturity influence the nascent conceptus, and beyond
por: Albertini, David F.
Publicado: (2020)

#NoJusticeNoSleep: Critical intersections of race-ethnicity, income, education, and social determinants in sleep health disparities
por: Dubar, Royette T.
Publicado: (2022)

Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial
por: Park, Hyun-Woong, et al.
Publicado: (2021)

High-Dose, but Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells
por: Grześk, Grzegorz, et al.
Publicado: (2013)

Erythropoietin therapy after out-of-hospital cardiac arrest: A systematic review and meta-analysis
por: Chaudhary, Rahul, et al.
Publicado: (2017)

Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2021)

Delta variant of COVID-19: A simple explanation
por: Hendaus, Mohamed A., et al.
Publicado: (2021)

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
por: Kim, Hyun Kuk, et al.
Publicado: (2021)

Oral healthcare disparities in Canada: filling in the gaps
por: Levy, Ben B., et al.
Publicado: (2022)

Partnering With Northern British Columbia First Nations in the Spectrum of Biobanking and Genomic Research: Moving Beyond the Disparities
por: Caron, Nadine R., et al.
Publicado: (2020)

A plausible explanation for male dominance in typhoid ileal perforation
por: Khan, Mohammad
Publicado: (2012)

An evolutionary explanation for antibiotics’ association with increased colon cancer risk
por: Voskarides, Konstantinos
Publicado: (2022)

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
por: Gorog, Diana A., et al.
Publicado: (2022)

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022)

Weird genotypes? Don't discard them, transmissible cancer could be an explanation
por: Riquet, Florentine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d6jbhdjk6ecdf614g863g955e8